Recombinant-follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment

Reproductive Medicine and Biology

Volumn 6, Issue 1, 2007, Pages 27-32

  Nakagawa, Koji ^a   Ohgi, Shirei ^a   Kojima, Rieko ^a   Sugawara, Kana ^a   Horikawa, Takashi ^a   Ito, Megumu ^a   Irahara, Minoaru ^b   Saito, Hidekazo ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Assisted reproductive technology; Ovarian stimulation; Recombinant follicles timulating hormone; Urinary hMG

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; FOLLITROPIN; GONATOROPIN; HUMAN MENOPAUSAL GONADOTROPIN; HUMEGON 75; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ESTROGEN BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STANDARDIZATION; TREATMENT DURATION;

EID: 33846957122     PISSN: 14455781     EISSN: 14470578     Source Type: Journal    
DOI: 10.1111/j.1447-0578.2007.00161.x     Document Type: Article

References (14)

1. Maruo T. Gonadotropin and its preparations. Comprehensive Handbook of Women's Medicine 7. Nakayama Shoten, 2000 ; 238-243.
2. Devroy P, Mannaerts B, Smitz J, Coelingh Bennink H, Van Steeirteghem A. Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotropin-releasing hormone agonist regimens. Hum Reprod 1994; 9: 1064-1069.
3. Matikainen T, De Leeuw R, Mannaerts B, Huhtaniemi I. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (org 324899 after administration to gonadotropin-deficient subjects. Fertil Steril 1994; 61: 62-69.
4. Voortman G, Mannaerts BMJL, Huisman AM. A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim/Puregon) in healthy female volunteers. Fertil Steril 2000; 73: 1187-1193.
5. Nakagawa K, Shirei O, Kojima R et al. Reduction of perifollicular arterial blood flow resistance after hCG administration is a good indicator of the recovery of mature oocytes in ART treatment. J Assist Reprod Genet 2007; in press.
6. Olijve W, de Boer W, Mulders JWM, van Wezenbeek PMGF. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon®). Mol Hum Reprod 1996; 2: 371-382.
7. Hedon B, Out HJ, Hugues JN et al. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial. Hum Reprod 1995; 10: 3102-3106.
8. Kubo H, Takeda S, Kinoshita K, Motoyama H, Kobayashi S, Morimoto Y. An open prospective multicentre study in pituitary suppressed Japanese women undergoing controlled ovarian hyperstimulation with recombinant follicle-stimulating hormone (Org 32489) to compare Japanese and European IVF results. Jap J Fertil Steril 2003; 48: 49-60.
9. van Wely M, Westergaard LG, Bossuyt PMM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2003; 1: CD003973. Review.
10. The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: A randomized, comparative trial. Fertil Steril 2002; 78: 520-528.
11. Ng EHY, Lau EYL, Yeung WSB, Ho PC. HMG is as good as recombinant FSH in terms of oocyte and embryo quality: A prospective randomized trial. Human Reprod 2001; 16: 319-325.
12. Mannaerts B, de Leeuw R, van Ravestein GA, van Wezenbeek P, Schurs A, Kloosterbore H. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology 1991; 129: 2623-2630.
13. Muasher SJ, Abdallah RT, Hubayter ZR. Optimal stimulation protocols for in vitro fertilization. Fertil Steril 2006; 86: 267-273.
14. Wang X, Otsu K, Saito H, Hiroi M, Ishikawa K. Sandwich configuration of type I collagen suppresses progesterone production in primary cultured porcine granulose cell by reducing expression of cytochrome P450 choresterol side-chain cleavage enzyme. Arch Biochem Biobys 2000; 376: 117-123.